Cited by 246Pluripotent Stem Cells ResearchCell death mechanisms and regulationMesenchymal stem cell research

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Inhibition of pluripotent stem cell-derived teratoma formation by small molecules

Open access

Lee, Mi-Ok, Moon, Sung Hwan, Jeong, Ho-Chang, Yi, Ji-Yeon, Lee, Tae-Hee, Shim, Sung Han, Rhee, Yong-Hee, Lee, Sang-Hun, Oh, Seok-Jeong, Lee, Moo-Yeol, Han, Min-Joon, Cho, Yee Sook, Chung, Hyung-Min, Kim, Kwang-Soo, Cha, Hyuk-Jin·2013·Proceedings of the National Academy of Sciences

DOI 10.1073/pnas.1303669110PMC PMC3761568

Open this paper in CoChat — free account

Abstract

The future of safe cell-based therapy rests on overcoming teratoma/tumor formation, in particular when using human pluripotent stem cells (hPSCs), such as human embryonic stem cells (hESCs) and human induced pluripotent stem cells (hiPSCs). Because the presence of a few remaining undifferentiated hPSCs can cause undesirable teratomas after transplantation, complete removal of these cells with no/minimal damage to differentiated cells is a prerequisite for clinical application of hPSC-based therapy. Having identified a unique hESC signature of pro- and antiapoptotic gene expression profile, we hypothesized that targeting hPSC-specific antiapoptotic factor(s) (i.e., survivin or Bcl10) represents an efficient strategy to selectively eliminate pluripotent cells with teratoma potential. Here we report the successful identification of small molecules that can effectively inhibit these antiapoptotic factors, leading to selective and efficient removal of pluripotent stem cells through apoptotic cell death. In particular, a single treatment of hESC-derived mixed population with chemical inhibitors of survivin (e.g., quercetin or YM155) induced selective and complete cell death of undifferentiated hPSCs. In contrast, differentiated cell types (e.g., dopamine neurons and smooth-muscle cells) derived from hPSCs survived well and maintained their functionality. We found that quercetin-induced selective cell death is caused by mitochondrial accumulation of p53 and is sufficient to prevent…

Integrity signals

Registry

Crossref · 10.1073/pnas.1303669110

Cites

0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
TAp63α induces apoptosis by activating signaling via death receptors and mitochondria
Gressner, O., Schilling, T., Lorenz, K., Schulze Schleithoff, E., Koch, A., Schulze‐Bergkamen, H., Maria Lena, A., Candi, E., Terrinoni, A., Valeria Catani, M., et al. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600708 · Cited by 255
Human Embryonic Stem Cells Have Enhanced Repair of Multiple Forms of DNA Damage
Maynard, S., Swistowska, A. M., Lee, J. W., Liu, Y., Liu, S.-T., Da Cruz, A. B., Rao, M., de Souza-Pinto, N. C., Zeng, X., & Bohr, V. A. (2008) · Stem Cells · doi:10.1634/stemcells.2007-1041 · Cited by 220
p53 regulation by ubiquitin
Brooks, C. L., & Gu, W. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.05.022 · Cited by 186

Show all 4 references

Research works printed but not linked: 63

10.1126/science.282.5391.1145 · DOI
10.1016/j.cell.2007.11.019 · DOI · Paper page
10.1038/nature10761 · DOI
10.1038/nrd2403 · DOI
10.1016/j.cell.2010.10.008 · DOI
10.1101/gad.1689808 · DOI
10.1016/S0065-230X(08)00005-5 · DOI
10.1038/nbt.1554 · DOI
10.1016/j.bmcl.2008.04.048 · DOI
10.1016/j.bmcl.2007.10.024 · DOI
10.4161/auto.4592 · DOI
10.1002/stem.321 · DOI
10.1634/stemcells.21-3-257 · DOI
10.1111/j.1471-4159.2006.03841.x · DOI
10.1038/nbt.1947 · DOI
10.1634/stemcells.2007-0576 · DOI
10.1002/stem.37 · DOI
10.1074/jbc.M610464200 · DOI
10.1158/0008-5472.CAN-09-4238 · DOI
10.1016/j.mrfmmm.2006.06.006 · DOI
10.1016/j.stem.2008.01.002 · DOI
10.1002/jcp.21735 · DOI
10.1016/j.molcel.2012.04.002 · DOI
10.5966/sctm.2012-0066 · DOI
10.1634/stemcells.2007-0401 · DOI
10.1038/nbt.1527 · DOI
10.1038/nm0897-917 · DOI
10.1172/JCI45794 · DOI
10.1038/nature03579 · DOI
10.1074/jbc.M407985200 · DOI
10.1124/jpet.108.148189 · DOI
10.1161/CIRCRESAHA.109.207902 · DOI
10.1016/S1097-2765(03)00050-9 · DOI
10.1093/emboj/20.23.6627 · DOI
10.1038/sj.onc.1210560 · DOI
10.1074/jbc.M300957200 · DOI
10.1091/mbc.e12-10-0771 · DOI
10.1038/nrc2293 · DOI
10.1016/j.canlet.2007.12.004 · DOI
10.1158/1535-7163.MCT-08-0236 · DOI
10.1158/0008-5472.CAN-07-1343 · DOI
10.1016/j.mad.2006.11.007 · DOI
10.1371/journal.pone.0030541 · DOI
10.1016/j.tcb.2009.12.004 · DOI
10.1038/ncb1211 · DOI
10.1038/sj.onc.1205353 · DOI
10.1093/emboj/17.16.4668 · DOI
10.1074/jbc.M800806200 · DOI
K Matsui, A Fine, B Zhu, A Marshak-Rothstein, ST Ju, Identification of two NF-kappa B sites in mouse CD95 ligand (Fas ligand) promoter: Functional analysis in T cell hybridoma. J Immunol 161, 3469–3473 (1998). · DOI
10.1038/ncb1087 · DOI
10.1111/j.1365-2443.2005.00835.x · DOI
CL Perkins, G Fang, CN Kim, KN Bhalla, The role of Apaf-1, caspase-9, and bid proteins in etoposide- or paclitaxel-induced mitochondrial events during apoptosis. Cancer Res 60, 1645–1653 (2000).
10.1038/sj.cdd.4401418 · DOI
10.1016/j.ejphar.2010.09.020 · DOI
10.1016/j.phrs.2010.05.001 · DOI
10.1080/07357900802337191 · DOI
10.1182/blood-2008-05-157198 · DOI
10.1084/jem.20062395 · DOI
10.1002/stem.121 · DOI
10.1111/j.1471-4159.2004.03006.x · DOI
10.1073/pnas.0605757103 · DOI
10.1038/srep00964 · DOI
10.1016/j.stem.2012.11.015 · DOI

Sorted by citations

Items 201–228 of 228

An Ethanol Extract of Coptidis rhizoma Induces Apoptotic Cell Death in Induced Pluripotent Stem Cells and Suppresses Teratoma Formation
Kim, A., Baek, S., Shin, S., Lee, S.-Y., & Chung, S.-K. (2023) · Nutrients · doi:10.3390/nu15102364 · Cited by 1
“Various strategies have been proposed to selectively remove undifferentiated iPSCs, including treatment with cytotoxic antibodies, small molecules, chemical inhibitors, and the insertion of a miRNA or suicide gene into iPSCs [7–9].”
BackgroundSelf-citation
Tissue inhibitor of metalloproteinase proteins inhibit teratoma growth in mice transplanted with pluripotent stem cells
Choi, K., Park, H.-K., Hwang, I.-S., Jeong, H., Park, H.-S., Jang, A., Namkung, Y., Hyun, D., Lee, S., Yoo, B. M., et al. (2019) · Stem Cells · doi:10.1002/stem.3132 · Cited by 1
Self-citation
NK cells prevent the formation of teratomas derived from human induced pluripotent stem cells
Benabdallah, B., Désaulniers-Langevin, C., Colas, C., Li, Y.-Y., Guimont, J. V., Haddad, É., & Beauséjour, C. (2019) · bioRxiv · doi:10.1101/714170 · Cited by 1
“To prevent the formation of teratomas, small molecules able to selectively and efficiently kill pluripotent cell by inhibiting antiapoptotic factors were developed [2; 3].”
Background
Scarless Enriched selection of Genome edited Human Pluripotent Stem Cells Using Induced Drug ResistancePreprint
Kim, K.-T., Park, J.-C., Lee, H., Jang, H.-K., Jin, Y., Kim, W., Lee, J., Kim, H., Bae, S., & Cha, H.-J. (2019) · bioRxiv · doi:10.1101/522383 · Cited by 1
Self-citation
Quantum oscillations in an anisotropic Weyl semimetal in crossed magnetic and electric fields
Алисултанов, З. З., Мусаев, Г. М., & Arslanbekova, M. M. (2017) · Low Temperature Physics · doi:10.1063/1.5012789 · Cited by 1
Induced Pluripotent Stem Cells: Next Generation Stem Cells to Clinical Applications
Cha, J.-M., Park, S., & Lee, S. B. (2015) · Hanyang Medical Reviews · doi:10.7599/hmr.2015.35.4.190 · Cited by 1
“to induce cell death of remaining iPSC after differentiation [12,13].”
BackgroundSelf-citation
Induced pluripotent stem cells in wound healing
Gao, X., Gorecka, J., Cheema, U., Gu, Y., Wu, Y., & Dardik, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822229-4.00003-6 · Cited by 3
Human-induced pluripotent stem cells (iPSC) as a source of insulin-producing cells
Pellegrini, S., & Sordi, V. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814831-0.00028-2 · Cited by 2
Cartilage Tissue Engineering and Regenerative Strategies
Morais, A. D. S., Oliveira, J. M., & Reis, R. L. (2016) · Studies in mechanobiology, tissue engineering and biomaterials · doi:10.1007/978-3-319-44785-8_5 · Cited by 1
Enrichment and Separation Technologies for Stem Cell-Based Therapies
Rodrigues, G., Fernandes, T. G., Rodrigues, C. A. V., Diogo, M. M., & Cabral, J. M. S. (2016) · Elsevier eBooks · doi:10.1016/b978-0-444-63265-4.00009-1 · Cited by 2
Multi-omics analysis and metabolic modeling reveal BCL2L1- and CPT1A-driven fatty acid oxidation in culture-adapted human embryonic stem cells with implications for cell therapy safety
Lee, S. W., Kim, Y.-J., Kang, S., Cha, H., & Kim, H. J. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.174074
Self-citation
Switching off CK2-mediated activation of survivin offers new therapeutic opportunities in neuroblastoma
Cazzanelli, G., Vedove, A. D., Broso, F., Burigotto, M., Zasso, J., Aiello, G., Zonta, F., Astolfi, A., Barreca, M. L., Ruzzene, M., et al. (2026) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01628-5
“The treatment with either CK2-TN03 or vehicle was started just after the stabilization of the tumor mass, to mimic what occurs in the clinical practice and performed via intraperitoneal injection.”
Biological tendon regeneration, are we almost there or is it still a stretch?
Pazarçeviren, A., Bastani, M., & Sheyn, D. (2025) · Regenerative medicine · doi:10.1080/17460751.2025.2546758
In silico chemical fingerprint screening identifies fisetin as a novel stemotoxic flavonoid
Lee, S., Kwon, E., Kim, D., Kim, J., Lee, S., Go, Y.-H., & Cha, H. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118369
Self-citation
Do human adipose stem cell-derived artificial insulin-producing cells develop tumorigenic characteristics throughout differentiation?
Babadi, P. S., Dayer, D., Jafarinia, M., & Forouzanfar, M. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10432-3
“Lee et al. designed a technique for inhibiting pluripotent stem cell-derived terato-mas by targeting hPSC-specific antiapoptotic proteins [14].”
Simple Procedure for the Isolation of Mesenchymal Stem Cells from Different Parts of the Human Umbilical Cord
Suyoko, A., Prasetyaningrum, P. W., & Septisetyani, E. P. (2022) · Indonesian Journal of Cancer Chemoprevention · doi:10.14499/indonesianjcanchemoprev13iss2pp104-113
TPX2 Induces Mitotic Survival via BCL2L1 Induction Through YAP1 Protein Stabilization in Human Embryonic Stem CellsPreprint
Kim, Y., Go, Y., Jeong, H.-C., Kim, S., Cheong, H., Shin, H., Lee, H., & Cha, H.-J. (2021) · Research Square · doi:10.21203/rs.3.rs-626430/v1
Self-citation
Killing pluripotent stem cells by BET protein inhibition
Ma, S., Lin, Y., & Rong, Z. (2018) · 中国科学通报：英文版 · doi:10.1016/j.scib.2018.04.006
Quantum electrical capacitance in epitaxial graphene
Alisultanov, Z., Rustamova, D., & Habibulaeva, A. M. (2015) · Low Temperature Physics · doi:10.1063/1.4936870
Demons resurrected from Angels! What are or are not the molecular clues of the rising of the teratoma or teratocarcinoma from human amniotic stem cell?
Rahman, M. S., Haque, M., & Asaduzzaman, S. (2015) · doi:10.7603/s40855-015-0002-1
Restoring Vision: Where are We with Stem Cells?
Zhu, J., & Lamba, D. A. (2015) · Current Ophthalmology Reports · doi:10.1007/s40135-015-0078-4
“detect and remove residual pluripotent cells in donor cells [13, 93–95].”
Background
Application of Induced Pluripotent Stem Cells in Rheumatology
Jung, S. M., & Ju, J. H. (2013) · Journal of Rheumatic Diseases · doi:10.4078/jrd.2013.20.5.286
Induced pluripotent stem cells for treatment of heart failure
Miyagawa, S., & Sawa, Y. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822229-4.00004-8
iPSCs and cell therapy for Parkinson’s disease
Schweitzer, J. S., Song, B., & Kim, K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822229-4.00005-x
Self-citation
Induced Pluripotent Stem Cells (iPSCs) Technology: Potential Targets for Depression
Colpo, G. D., & Teixeira, A. L. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-33-6044-0_24
Tumorigenesis and Biomaterials
Jo, V. Y., & Schöen, F. J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816137-1.00053-2
Characterization of in vitro systems to generate oocytes and substitutes of sperm from pluripotent stem cells
Aizawa, E. (2019) · doi:10.3929/ethz-b-000391005
“For example, a chemical inhibitor of human ESC- and iPSC-specific antiapoptotic factors, quercetin, induced selective and efficient cell death of undifferentiated human PSCs in several differentiated cell types including dopamine neurons and smooth-muscle cells (Lee et al., 2013).”
Background
Myocardial Infarction: Cell Therapy for Cardiac Regeneration
Bartulos, O. (2015) · doi:10.16966/2379-769x.103
“[85] developed a clinicalgrade strategy using small molecules against survivin.”

Authors: Lee, M.-O., Moon, S. H., Jeong, H.-C., Yi, J.-Y., Lee, T.-H., Shim, S. H., Rhee, Y.-H., Lee, S.-H., Oh, S.-J., Lee, M.-Y., Han, M.-J., Cho, Y. S., Chung, H.-M., Kim, K.-S., & Cha, H.-J.
Affiliations: Sogang University (KR)
CHA University (KR)
Sejong University (KR)
Hanyang University (KR)
Dongguk University (KR)
Harvard University (US)
Korea Research Institute of Bioscience and Biotechnology (KR)
Konkuk University (KR)
ORCID: Lee, Mi-Ok
Moon, Sung Hwan
Jeong, Ho-Chang
Lee, Tae-Hee
Shim, Sung Han
Lee, Sang-Hun
Lee, Moo-Yeol
Han, Min-Joon
Cho, Yee Sook
Chung, Hyung-Min
Kim, Kwang-Soo
Cha, Hyuk-Jin
Venue: Proceedings of the National Academy of Sciences
Publisher: National Academy of Sciences
Published: 2013-08-05
Volume: 110
Issue: 35
Pages: E3281-90
ISSN: 0027-8424 (ISSN-L)
1091-6490
DOI: 10.1073/pnas.1303669110
PMC: PMC3761568
OpenAlex: W2065594892
Cited by: 246
References: 68
Citations by year: 2026: 5 · 2025: 12 · 2024: 18 · 2023: 15 · 2022: 16 · 2021: 21 · 2020: 19 · 2019: 22 · 2018: 16 · 2017: 21 · 2016: 32 · 2015: 24 · 2014: 20 · 2013: 5
FWCI: 12.10
Type: journal article
Language: en
Open access: green
europepmc.org
Locations: Proceedings of the National Academy of Sciences (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
KRIBB Repository (submittedVersion)
Seoul National University Open Repository (Seoul National University) (submittedVersion)
Funders: National Institute of Neurological Disorders and Stroke (R01NS070577, NS070577)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
Keywords: teratoma prevention, human pluripotent stem cells, human embryonic stem cells, human induced pluripotent stem cells, small molecule inhibitors, survivin, BCL10, quercetin, YM155, selective cell death, apoptosis, p53, dopaminergic neurons, smooth muscle cells
MeSH terms: B-Cell CLL-Lymphoma 10 Protein, Survivin, Cell Differentiation, Cells, Cultured, Humans, Imidazoles, Mitochondria, Naphthoquinones, Teratoma, Tumor Suppressor Protein p53, Apoptosis, Gene Expression Profiling, Stem Cell Transplantation, Pluripotent Stem Cells, Adaptor Proteins, Signal Transducing, Inhibitor of Apoptosis Proteins, Small Molecule Libraries

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Inhibition of pluripotent stem cell-derived teratoma formation by small molecules

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Metadata

Record

About these checks